Last reviewed · How we verify

NCT05378139

Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization

Recruiting now Last updated 11 April 2025
What this trial tests

trial testing Vital signs measurements with new app in Surgical Complication in 3,095 participants. Currently enrolling.

Timeline
1 February 2021
Primary endpoint
27 June 2025
22 December 2025

Quick facts

Lead sponsorUniversity Hospital Bispebjerg and Frederiksberg
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment3,095
Start date1 February 2021
Primary completion27 June 2025
Estimated completion22 December 2025
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital Bispebjerg and Frederiksberg

Who can join

18 and older, any sex, with Surgical Complication or Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of this study is to test and assess the implementation and effectiveness of continuous wireless vital signs monitoring with real-time alerts on: The frequency of patients monitored with adequate data quality as adequate clinical user satisfaction in the initial versus the last part of the trial (primary outcome).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Surgical Complication

Currently open trials in the same condition.

Other University Hospital Bispebjerg and Frederiksberg trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05378139.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing